Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
ReBio logo — Through The Lens of Progress

ReBio

Through The Lens of Progress

Founded 2015 Finland Finland 22 employees Grant Total: $5.41M Biotechnology, Health Care +1

General Information

Company Name ReBio
Founded Year 2015
Location Finland Finland +3
Employees 22
Industries Biotechnology, Health Care, Manufacturing
Funding Stage Grant
Social

Get notified when ReBio moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About ReBio

ReBio Technologies is a biotechnology startup based in Finland, founded in 2014. With its slogan "Through The Lens of Progress," the company has developed SiSu®, a proprietary formulation technology solving safety and efficacy challenges in sustained release approaches. SiSu® is tailored to steadily release therapeutics within the eye, dissolving safely once drug release is complete. This innovative technology is poised to transform the standard of care for millions of patients with chronic eye diseases. The latest investment of €410.00K was secured through a grant in January 2020, with Business Finland being the investor. To learn more, visit www.rebiopharma.com.

Taxonomy: Biotech, Ophthalmology, Drug Delivery, Sustained Release Technology, Chronic Eye Disorders, SiSu® Technology, Innovation, Medical Franchise, Surrey, United Kingdom, Start-up, Biomedical Research

Funding Rounds & Investors (3)

View All
Funding Stage Amount Investors Lead Investors Date
Grant •••••• 1
Investor
07 Jan 2020
Seed Round •••••• 2
Investor Investor
13 Nov 2018
Seed Round •••••• 1
Investor
27 Nov 2014

ReBio Alternatives & Competitors

ReBio vs
Redwood Pharma AB (publ.)
Redwood Pharma AB (publ.) Sweden

We develop ophthalmic drugs that address major medical needs.

2 employees
Health Care, Pharmaceutical
ReBio vs
Advanced Ophthalmic Pharma
Advanced Ophthalmic Pharma

Pioneering a new way in eye care with a preservative-free mist application for ophthalmic treatments...

Series Unknown
Biotechnology, Pharmaceutical
ReBio vs
PolyActiva
PolyActiva Australia

Enabling Drug Delivery from Medical Devices

Series B
24 employees
Biotechnology, Health Care

FAQ About ReBio

Through The Lens of Progress
ReBio was founded in 2015.
ReBio is headquartered in Finland.
ReBio operates in the following industries: Biotechnology, Health Care, Manufacturing.
ReBio has approximately 22 employees.
ReBio has completed 3 funding rounds, raising a total of $5.41M. The latest funding stage is Grant.
Top alternatives and competitors to ReBio include Redwood Pharma AB (publ.), Advanced Ophthalmic Pharma, PolyActiva, EyeD Pharma, Drug Development & Delivery. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
ReBio and Redwood Pharma AB (publ.) are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors ReBio and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy